Investigation Of Prophylactic Drug Use Adherence By Patients With Migraine

Adherence to Prophilactic Drug Use in Migraine Patients


  • Ezgi Can a:1:{s:5:"en_US";s:6:"hayır";}
  • Tuğba Tunç


migraine, drug, treatment, prophilactic treatment, compliance, tablet counting method, health


Aim: Adherences to drug use; it is a very important part of patient care and clinical brief. Non-compliance with prescribed treatment regimens is an important and common behavioral health problem in the treatment of chronic diseases. In our study, it was aimed to investigate the rate of adherence to medication use in migraine patients taking prophylactic drug, the factors affecting it, and the reasons for decreased compliance.
Methods: Eighty patients diagnosed with migraine and using prophylactic treatment for migraine were included in the study. Detailed sociodemographic and clinical histories were taken at the first interview. The scores obtained by applying the Beck Anxiety and Depression Inventory were recorded for each patient. The patients were evaluated with weekly visits for four weeks; adherence was examined by tablet counting method.
Results: In our study, % 70 of our patients who received prophylactic drug for migraine were non-compliant with the treatment; it was observed that the three most common causes were forgetting to take medication, drug side effects and drug expiration. It was observed that low education level, being married, diet and exercise incompatibility, and high sleep problems, depression and anxiety symptoms affected the adherence to prophylactic drug use in a statistically significant.
Conclusion: To increase the patient's compliance to follow the treatment regimen, all potential barriers to compliance must be considered. Measures that take into account the factors under the patient's control and the interaction between patient and physician and patient-health care will have the greatest impact on improving adherence. This will lead to better clinical outcomes and decrease in morbidity and health expenditures.

Author Biography

Tuğba Tunç

Ezgi Can, MD
Gazi University Faculty of Medicine, Department of Neurology, Ankara/ Turkey
Email :
ORCID : 0000-0002-9902-3485

Tuğba Tunç, MD
Gazi University Faculty of Medicine, Department of Neurology, Ankara/ Turkey
Email :
ORCID : 0000-0001-6510-7931






Original Research